Advanced oesophageal cancer - Search for the best procedure [1]

Medical Science Monitor

Volumn 9, Issue 4, 2003, Pages

  Strutyńska Karpińska, Marta ^a   Knast, Witold ^a   Markocka Ma̧czka, Krystyna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; ESOPHAGUS CANCER; LETTER; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; QUALITY OF LIFE; SURVIVAL RATE;

EID: 0037883332     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Daly JM, Karnell LH, Menck HR: National Cancer Data Base Report on Esophageal Carcinoma. Cancer, 1996: 78: 1820-1828.
2. Bonavina L: Early oesophageal cancer: results of a European multi-centre survey. Br J Surg, 1995; 82: 98-101.
3. Kodama M. Kakegawa T: Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire of superficial cancer of the esophagus in Japan. Surgery, 1998; 123: 432-439.
4. Strutyńska-Karpińska M, Blaszcuk J, Grabowski K, Milnerowicz S: Advancement of oesophageal cancer in patients referred for surgery. Gastroenterol Pol. 2002; 9: 183-187.
5. O'Hanlon DM, Harkin M, Karat D at al: Quality-of-life assessment in patients undregoing tratment for oesophageal carcinoma, Br J Surg. 1995; 82: 1200-1203.
6. Tamin WZ, Davidson RS, Quinlan RM et al: Neoadjuvant chemotherapy for esophageal cancer. Is it worthwhile? Arch Surg, 1998; 133: 722-726.
7. Nishimaki T, Suzuki T, Suzuki S et al: Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg, 1998; 186: 306-312.
8. Coia LR, Minsky BD, Berkey BA et al: Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 patterns of care study. J Clin Oncol, 2000; 18: 455-462.
9. Heath EI, Burtness BA, Heitmiller RF et al: Phase II evaluation of preoperative chemoradiation and postoperative adjuvaut chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol, 2000; 18: 868-876.